This review synthesizes multi-omics insights into SERPINE2-driven microenvironmental reprogramming and discusses emerging therapeutic strategies integrating molecular targeting and immunotherapy in metastatic cancers. This evidence concerns the gene SERPINE2 and metastatic malignant neoplasm.